A special 1-day partnering program focused on business development opportunities in the cell and gene therapy sectors. The program highlights opportunities for valuable partnerships, best practices for collaborating with new stakeholders, the latest research developments, plus commercialization and market access solutions. As an added benefit, partneringONE® is available to help you create a meeting schedule to enable you to meet with potential partners.
Cancer Stem Cell Conference (CSC 2018), hosted by the Case Comprehensive Cancer Center and National Center for Regenerative Medicine, is designed to bring together individuals working in the field of cancer stem cell research. CSC 2018 will feature renowned keynote speakers and leaders in the field. This conference is guaranteed to have cutting-edge research from a variety of niches within the field. Join us August 6-8, 2018 in Cleveland!
CRISPRcon returns June 4-5, 2018 in Boston, MA to advance broad dialogue on whether and how gene editing technologies should make the transition from the lab into society at-large. The event features a dynamic, diverse, and provocative lineup of panels, keynotes, interactive discussions, and networking opportunities that consider gene editing across a variety of applications, disciplines, geographies, communities, and cultures.
MarketsandMarkets has put together a platform for the leading experts of industry to discuss strategies, technologies and innovations in tissue engineering & biomaterials, cellular therapies and diagnosis of regenerative medicines at the Next-Gen Regenerative Medicine & Tissue Engineering Conference.
The event is meant to provide a “speaker’s corner” for those who seek to engage partnerships with Japanese companies with respect to the development of their own product pipelines and/or technology seeds in Japan.
Join us April 9-12, 2018 for Cell & Gene Therapy Manufacturing Digital Week, a 4-day series of live educational webcasts and downloadable resources help you improve processes, capabilities, and analytical strategies.
The Advanced Therapies Summit is a gathering of top executives and policy makers leading the evolution of the ATMP framework in Europe and key member states. This year’s program will feature roundtable discussions and networking opportunities.
BIO-Europe Spring® is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups.
